Fund shareholders of Alnylam Pharmaceuticals Inc
ISIN US02043Q1076 · United States · LEI 529900S3ZI14OWRJII50
- Fund shareholders
- 760
- Of which ETFs
- 211 549 other funds
- Value held
- 24.8B $ 1.4B SEK · 14.6M €
- Share of capital
- 56.7 % of 133.8M shares on Jul 24, 2026
760 funds hold this company. This table lists the 756 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 92 | 30.6K $ | 0.34 % | 0.00 % | as of Feb 28, 2026 ↗ |
| First Trust Bloomberg R&D Leaders ETF First Trust Exchange-Traded Fund VI | 86 | 28.5K $ | 0.69 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AQR MS Fusion HV Fund AQR Funds | 84 | 27.8K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Hartford Schroders Diversified Opportunities Fund HARTFORD MUTUAL FUNDS II, INC | 79 | 24.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SPP Generation 40-tal Storebrand Asset Management AS | 69 | 217.5K SEK | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Sector Rotation Fund Meeder Funds | 66 | 21.8K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Eventide Large Cap Value ETF Strategy Shares | 65 | 20.1K $ | 0.17 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Global Strategist Portfolio MORGAN STANLEY VARIABLE INSURANCE FUND INC. | 57 | 18.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Dimensional U.S. Equity Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 55 | 18.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 52 | 16.1K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree Technology and Innovation 100 Digital Fund WisdomTree Digital Trust | 48 | 15.9K $ | 0.34 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Catalyst Nasdaq - 100 Hedged Equity Fund MUTUAL FUND SERIES TRUST | 39 | 12.9K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Schroders VCP Global Allocation Portfolio SUNAMERICA SERIES TRUST | 35 | 10.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| NYLI Global Equity R&D Leaders ETF New York Life Investments ETF Trust | 34 | 10.5K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree 500 Digital Fund WisdomTree Digital Trust | 32 | 10.6K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares ESG Optimized MSCI USA Min Vol Factor ETF iShares Trust | 32 | 9.9K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 30 | 9.9K $ | 0.33 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AB US Equity ETF AB Active ETFs, Inc. | 27 | 9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Global X NASDAQ 100 Collar 95-110 ETF GLOBAL X FUNDS | 27 | 8.4K $ | 0.21 % | 0.00 % | as of Apr 30, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 25 | 8.3K $ | 0.37 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Active Core U.S. Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 23 | 7.6K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator Hedged Nasdaq-100 ETF Innovator ETFs Trust | 21 | 6.5K $ | 0.22 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Global X NASDAQ 100 Tail Risk ETF GLOBAL X FUNDS | 19 | 5.9K $ | 0.20 % | 0.00 % | as of Apr 30, 2026 ↗ |
| KraneShares InspereX Nasdaq Dynamic Buffered High Income Index ETF Krane Shares Trust | 17 | 5.6K $ | 0.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Enhanced Large Cap Core Active ETF BlackRock ETF Trust | 17 | 5.3K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Storebrand Global Developed Markets Storebrand Asset Management AS | 16 | 50.4K SEK | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morningstar Alternatives Fund Morningstar Funds Trust | 15 | 4.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator Equity Premium Income - Daily PutWrite ETF Innovator ETFs Trust | 15 | 4.6K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 12 | 4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Hedged Equity Portfolio Variable Insurance Products Fund VI | 12 | 4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Russell 1000 Momentum Focus ETF SPDR SERIES TRUST | 11 | 3.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) MSCI USA Climate Paris Aligned ETF SPDR SERIES TRUST | 11 | 3.6K $ | 0.14 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Nasdaq-100 Dynamic Buffer ETF ProShares Trust | 9 | 3K $ | 0.23 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Global X U.S. 500 ETF GLOBAL X FUNDS | 9 | 3K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Vox Populi ETF Advisors Series Trust | 9 | 2.8K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| FIIG ESG STOCK PLAN FOR RETIREMENT Unified Series Trust | 6 | 2K $ | 0.51 % | 0.00 % | as of Feb 28, 2026 ↗ |
| FIIG STOCK FUND FOR RETIREMENT Unified Series Trust | 5 | 1.7K $ | 0.43 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 5 | 1.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| WisdomTree Efficient U.S. Plus International Equity Fund WisdomTree Trust | 4 | 1.3K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Dynamic Buffered Equity ETF Fidelity Greenwood Street Trust | 2 | 619 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| CAIXABANK MULTISALUD, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 3.9M € | 0.60 % | as of Dec 31, 2025 ↗ | ||
| BBVA GLOBAL DESARROLLO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 3.7M € | 0.49 % | as of Dec 31, 2025 ↗ | ||
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 3.6M € | 2.04 % | as of Dec 31, 2025 ↗ | ||
| MERCH-UNIVERSAL, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 1.6M € | 1.78 % | as of Dec 31, 2025 ↗ | ||
| DUNAS SELECCIÓN USA ESG CUBIERTO FI DUNAS CAPITAL ASSET MANAGEMENT S.G.I.I.C., S.A. | 554.4K € | 0.16 % | as of Dec 31, 2025 ↗ | ||
| SIGMA INVESTMENT HOUSE HEALTHCARE, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 253.9K € | 0.65 % | as of Dec 31, 2025 ↗ | ||
| PATRIBOND, FI PATRIVALOR, SGIIC, S.A. | 203.1K € | 0.26 % | as of Dec 31, 2025 ↗ | ||
| PATRIVAL, FI PATRIVALOR, SGIIC, S.A. | 169.3K € | 0.25 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 146.6K € | 3.99 % | as of Dec 31, 2025 ↗ | ||
| FONDO NARANJA NASDAQ 100, FI AMUNDI IBERIA, SGIIC, S.A. | 129.7K € | 0.28 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 95.1K € | 0.01 % | as of Dec 31, 2025 ↗ | ||
| ARQUIA BANCA LIDERES DEL FUTURO, FI ARQUIGEST, S.A., S.G.I.I.C. | 77.8K € | 0.79 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 69.1K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 27.1K € | 0.81 % | as of Dec 31, 2025 ↗ | ||
| SABADELL PLANIFICACION, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 25.7K € | 0.01 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 70, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 24.4K € | 0.04 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 5.52 % | as of Apr 30, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.84 % | as of Apr 30, 2026 ↗ |
| Nestyield Dynamic Income ETF Tidal Trust III | 4.66 % | as of Feb 28, 2026 ↗ |
| NestYield Visionary ETF Tidal Trust III | 4.62 % | as of Feb 28, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 4.14 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 4.11 % | as of Mar 31, 2026 ↗ |
| Nestyield Total Return Guard ETF Tidal Trust III | 4.06 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 3.99 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.99 % | as of Dec 31, 2025 ↗ |
| VANGUARD BAILLIE GIFFORD GLOBAL POSITIVE IMPACT STOCK FUND VANGUARD VALLEY FORGE FUNDS | 3.46 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 696 | +10 | 75,428,168 | +1.0 % |
| 2026Q1 | 686 | +34 | 74,668,226 | +1.3 % |
| 2025Q4 | 652 | +34 | 73,684,788 | -2.6 % |
| 2025Q3 | 618 | -6 | 75,686,877 | +2.2 % |
| 2025Q2 | 624 | +46 | 74,063,375 | -0.1 % |
| 2025Q1 | 578 | -8 | 74,152,711 | -1.2 % |
| 2024Q4 | 586 | +51 | 75,034,343 | +9.1 % |
| 2024Q3 | 535 | +19 | 68,756,140 | +5.3 % |
| 2024Q2 | 516 | -5 | 65,297,179 | +1.9 % |
| 2024Q1 | 521 | -7 | 64,072,072 | -8.1 % |
| 2023Q4 | 528 | 69,739,098 |
Institutional managers
775 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 14,579,166 | 4.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 10,802,348 | 3.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,444,908 | 3.5B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 9,471,181 | 3.1B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,323,752 | 2B $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,193,324 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,322,698 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,660,385 | 884.6M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 2,493,866 | 825.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | 659.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,935,925 | 640.5M $ | as of Mar 31, 2026 |
| Dodge & Cox | 1,929,253 | 638.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,802,363 | 596.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,432,748 | 474.1K $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,356,036 | 448.7M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 1,334,825 | 441.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,291,726 | 427.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,099,318 | 363.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,059,062 | 350.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,002,681 | 331.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 966,912 | 319.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 934,881 | 309.3M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | 297.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 858,120 | 283.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 838,187 | 277.3M $ | as of Mar 31, 2026 |
Declared shareholders of Alnylam Pharmaceuticals Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 11.00 % | 14,640,525 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital World Investors | 8.20 % | 10,916,799 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 7.10 % | 9,471,181 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.35 % | 7,104,536 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Alnylam Pharmaceuticals Inc
33 funds declare 42 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Alnylam Pharmaceuticals Inc". https://titelia.com/en/stocks/alnylam-pharmaceuticals-inc-US02043Q1076